RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

298 hedge funds and large institutions have $4.77B invested in Ultragenyx Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 112 increasing their positions, 91 reducing their positions, and 30 closing their positions.

Holders
298
Holders Change
+24
Holders Change %
+8.76%
% of All Funds
4.31%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
56
Increased
112
Reduced
91
Closed
30
Calls
$28.2M
Puts
$23.9M
Net Calls
+$4.32M
Net Calls Change
-$3.45M

Top Buyers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$65M
2
AQR Capital Management
2
AQR Capital Management
Connecticut
$57.8M
3
Alkeon Capital Management
3
Alkeon Capital Management
New York
$167M
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$54.9M
5
Invesco
5
Invesco
Georgia
$93M

Top Sellers

1
RI
1
RTW Investments
New York
$109M
2
Millennium Management
2
Millennium Management
New York
$39.5M
3
VPC
3
Vestal Point Capital
New York
$41.7M
4
SCM
4
Suvretta Capital Management
New York
$64M
5
Norges Bank
5
Norges Bank
Norway
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of New York Mellon
26
Bank of New York Mellon
New York
$42.9M 772,085 -9,858 -1%
Two Sigma Investments
27
Two Sigma Investments
New York
$42M 755,683 +187,374 +33%
FLAM
28
First Light Asset Management
Minnesota
$41.9M 755,102 -208,044 -22%
APM
29
Avidity Partners Management
Texas
$41.8M 752,000 -208,000 -22%
VPC
30
Vestal Point Capital
New York
$41.7M 750,000 -1,050,000 -58%
BNP Paribas Asset Management
31
BNP Paribas Asset Management
France
$40.2M 724,182 -106,193 -13%
CS
32
Candriam SCA
Luxembourg
$39.6M 713,092 +24,150 +4%
Millennium Management
33
Millennium Management
New York
$39.5M 710,689 -1,140,045 -62%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$36.3M 653,660 +113,911 +21%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$35.4M 637,821 -9,797 -2%
FLSM
36
Frazier Life Sciences Management
California
$35.2M 633,715 +208,715 +49%
Charles Schwab
37
Charles Schwab
California
$33M 594,521 +56,905 +11%
EA
38
Emerald Advisers
Pennsylvania
$31.7M 569,798 +83,116 +17%
EHI
39
Eagle Health Investments
Connecticut
$31.2M 561,700 +37,200 +7%
Massachusetts Financial Services
40
Massachusetts Financial Services
Massachusetts
$30.1M 542,373 +172,126 +46%
FAM
41
Fred Alger Management
New York
$29.8M 536,298 -12,607 -2%
Pictet Asset Management
42
Pictet Asset Management
Switzerland
$28.3M 520,550 -36,268 -7%
Goldman Sachs
43
Goldman Sachs
New York
$28.1M 506,510 -123,004 -20%
Northern Trust
44
Northern Trust
Illinois
$26.3M 473,324 +91,443 +24%
Morgan Stanley
45
Morgan Stanley
New York
$26M 467,836 -30,133 -6%
GKIM
46
GW&K Investment Management
Massachusetts
$25.9M 466,569 +60,050 +15%
EMFAT
47
Emerald Mutual Fund Advisers Trust
Pennsylvania
$23.8M 429,302 +38,778 +10%
Axa
48
Axa
France
$23.6M 425,390 +56 +0%
SSA
49
Schonfeld Strategic Advisors
New York
$22.3M 400,833 -316,114 -44%
Nuveen Asset Management
50
Nuveen Asset Management
Illinois
$21.8M 392,760 +188,537 +92%
1
2
3 4 5